Corbus Pharmaceuticals Holdings Inc - ESG Rating & Company Profile powered by AI
Browse to the bottom of this webpage for potential risks for Corbus Pharmaceuticals Holdings Inc based on industry, location and size. The webpage displays a zero-cost E,S&G assessment for Corbus Pharmaceuticals Holdings Inc. This ESG score covers 17 United Nations Sustainable Development Goals including: 'Zero Hunger', 'Sustainable Cities & Communities' and 'Life below Water'.
Corbus Pharmaceuticals Holdings Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.0; made up of an environmental score of 2.7, social score of 3.2 and governance score of 6.0.
4.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
989 | Spectrum Pharmaceuticals Inc | 4.1 | High |
989 | Tricida Inc | 4.1 | High |
1004 | Corbus Pharmaceuticals Holdings Inc | 4.0 | High |
1004 | Can B Corp | 4.0 | High |
1004 | CLS Holdings USA Inc | 4.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Corbus Pharmaceuticals Holdings Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc report the average age of the workforce?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc offer flexible work?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc conduct supply chain audits?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose water use targets?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Corbus Pharmaceuticals Holdings Inc have a product recall in the last two years?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Corbus Pharmaceuticals Holdings Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose parental leave metrics?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Corbus Pharmaceuticals Holdings Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose its waste policy?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc report according to TCFD requirements?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose energy use targets?
Sign up for free to unlockDoes Corbus Pharmaceuticals Holdings Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Corbus Pharmaceuticals Holdings Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Corbus Pharmaceuticals Holdings Inc
These potential risks are based on the size, segment and geographies of the company.
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics that target the endocannabinoid system in the fields of autoimmunity, fibrosis, and cancer. Its lead product candidate is lenabasum, a cannabinoid receptor type 2 (CB2) that is in Phase III clinical trial for the treatment of dermatomyositis; and in Phase II clinical trial to treat systemic lupus erythematosus. The company is also developing cannabinoid receptor type 1 inverse agonist program for treatment of metabolic disorders, such as obesity, diabetic nephropathy, diabetic retinopathy, and nonalcoholic steatohepatitis; and CB2 agonist program for the treatment of cancer. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, which includes the Jenrin library of approximately 600 compounds and multiple issued and pending patent filings; and strategic collaboration with Kaken Pharmaceutical Co., Ltd. for the development and commercialization of lenabasum in Japan. The company was incorporated in 2009 and is based in Norwood, Massachusetts.